Blog
Could Novo Nordisk Help Turn $100,000 Into $1 Million in the GLP‑1 Gold Rush?
Novo Nordisk's (NYSE: NVO) shares have lagged the market over the past couple of years. However, the Denmark-based pharmaceutical specialist remains one of the undisputed leaders in the GLP-1 drug
Apellis (APLS) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, Feb. 24, 2026 at 8:30 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Forget D-Wave Quantum: This Big Tech AI Leader Is Quietly Building the Stronger Moat
Quantum computing stocks like D-Wave Quantum and IonQ are promising breakthroughs that could reshape industries. But, for now, commercial deployments of these quantum computing solutions remain
The AI Stock That Insiders Are Loading Up On for 2026
Insider buying is one of the best indicators of how a stock might perform in the future.
The people running a company or who sit on its board of directors know it best. How could they not? They know
Nano Nuclear Energy Stock Is Down 60%. Is It Finally Time to Buy?
Nuclear energy is enjoying a revival as countries and companies see it as an effective way to meet the growing energy demand from data centers. One promising company developing next-generation micro
How Prediction Market Traders Won on Domino's Earnings Miss
Traders looking for a potentially tasty way to kick off the week may have considered Domino's Pizza (NASDAQ: DPZ), which delivered fourth-quarter results on Monday morning.
Pizza aficionados and
Why Is Meta Platforms Stock Underperforming?
As of this writing, shares of social media and digital advertising giant Meta Platforms (NASDAQ: META) are down about 3% in 2026. The S&P 500 is up close to 1% over the same stretch.
The
3 Top Dividend Stocks to Double Up on Right Now
The S&P 500 (SNPINDEX: ^GSPC) is offering investors a tiny 1.1% yield. You can do way better than that with reliable dividend growth stocks like Enterprise Products Partners (NYSE: EPD), Realty
Rocket Lab Is Days From a Major Earnings Report -- and Bettors Are Quietly Getting Bullish
Lately, space stocks have taken off like, well, rockets. Among these, Rocket Lab (NASDAQ: RKLB) has done particularly well, although it's down from its peak due to a failure in late-stage testing
Are the Signs Pointing to Another Nasdaq-100 Correction?
At some point in 2024, market sentiment began to shift. Even though the Nasdaq-100 was continuing to set new all-time highs, the number of stocks trading above their 200-day moving average declined
Nvidia Earnings: What to Watch for on Feb. 25
One of the most-watched events of the quarter is happening in just a few hours: Nvidia (NASDAQ: NVDA) is set to report fourth-quarter and fiscal 2026 earnings. The report is scheduled for Feb. 25
Is This Super Software Stock a Buy After Its Dramatic 86% Decline? Here's What Wall Street Thinks
Bill Holdings (NYSE: BILL) offers a portfolio of software products designed to help small and medium-sized businesses (SMBs) manage their accounts receivable, accounts payable, and budgeting
Prediction: SoundHound AI Stock Will Soar in 2026
At times this year, artificial intelligence (AI) stocks led the market sharply higher. And at other times, these stocks were a major drag on market indexes.
SoundHound AI (NASDAQ: SOUN) has been no
Investment Firm Absoluto Partners Bought Over 7,000 Shares in MercadoLibre. Is the Stock a Buy?
Investment management company Absoluto Partners Gestao de Recursos Ltda disclosed a buy of 7,285 MercadoLibre (NASDAQ:MELI) shares, with an estimated transaction value of $15.30 million based on
Where Will Rigetti Computing Be by 2030?
Rigetti Computing (NASDAQ: RGTI) stock has come back to Earth -- somewhat. After riding a wave of enthusiasm to $58, shares now sit around $16.
The bull case requires a lot to go right: Rigetti must
Why Apple Stock Ascended Today
Shares of Apple (NASDAQ: AAPL) rose on Tuesday after the technology titan highlighted its progress toward bringing more of its manufacturing operations to the U.S.
By the close of trading, Apple's
The eVTOL Company No One Is Talking About (Hint: It's Not Joby Aviation or Archer)
In these early days of electric vertical takeoff and landing (eVTOL) flight, there are the usual suspects. Joby Aviation (NYSE: JOBY) and Archer Aviation (NYSE: ACHR) are two companies at the
The Best Stocks to Invest $50,000 in Right Now
Let's face it. Investing $50,000 is much more daunting than investing $1,000. For some people, the latter figure is a somewhat disposable amount of money that can be risked. The former number
Why Eli Lilly Stock Slumped Today
A price war for weight-loss drugs is intensifying, and it's clear Eli Lilly (NYSE: LLY) investors weren't happy about it. On news that the company's arch-rival in the category had cut prices for
The 2 Biggest Earnings Risks Facing Interactive Brokers in 2026
Interactive Brokers (NASDAQ: IBKR) has delivered impressive earnings growth over the past few years. Its automated platform, global reach, and disciplined cost structure have turned it into one of
Prediction: Agentic AI Will Be the Biggest Tech Trend of 2026. Here Are 2 Stocks to Own
Artificial intelligence (AI) is changing the world we live in, and the next big change is coming in the form of AI agents. Many agentic AI stocks have been thrown out with the bathwater during the
Why Leonardo DRS Stock Trounced the Market Today
Leonardo DRS (NASDAQ: DRS) was a defense sector stock of choice for many market participants on the second trading day of the week. The company's shares zoomed almost 15% higher on the back of a
2 Reasons Regeneron Stock Could Crush the Market for the Next 10 Years
Healthcare stocks have underperformed broader equities in recent years. But plenty of companies in the sector still look like good long-term bets.
Take Regeneron Pharmaceuticals (NASDAQ: REGN), a
Investment Advisor Trims Frontier Group Holdings Stock Worth $3.1 Million, According to Recent SEC Filing
On February 17, 2026, Ancient Art, L.P. reported selling 700,000 shares of Frontier Group Holdings (NASDAQ:ULCC), an estimated $3.10 million trade based on quarterly average pricing.
According to a
ValueAct Just Doubled Its Stake in This Beaten-Up SaaS Name. Should Investors Be Buying the Stock?
ValueAct Capital Management made a name for itself as one of the top hedge funds in the industry. The fund invests in a concentrated portfolio of stocks, with a focus on high-quality businesses that


